Alpha Biopharma Announces Series A Financing

SHANGHAI, June 19, 2018 -- (Healthcare Sales & Marketing Network)-- Alpha Biopharma Inc. ("AlphaBio") today announced the first $37M closing of its $65M Series A financing led by Qiming Venture Partners, one of the most prominent venture capita...Biopharmaceuticals, Oncology, Venture Capital, Personnel
Alpha Biopharma, NSCLC, tyrosine kinase inhibitor